Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
December 10, 2018
Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast Cancer Symposium (SABCS)
December 7, 2018
Millendo Therapeutics Announces Successful Merger Completion
December 6, 2018
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
December 3, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego
December 1, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
November 20, 2018
Sandoz and Pear Therapeutics Announce Launch Of reSET® For Treatment Of Patients With Substance Disorder
November 14, 2018
Cidara Therapeutics Named a San Diego Metro Area Top Workplace for Second Consecutive Year
November 14, 2018
Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results
November 14, 2018
Homology Medicines Reports Third Quarter 2018 Financial Results
November 13, 2018
5AM Welcomes New Team Members: Partner Deborah Palestrant, Venture Partner Elliot Ehrich, General Counsel Galya Blachman
« Previous Page
1
…
56
57
58
59
60
…
103